Robert Gries Jr., a director of Slide Insurance Holdings Inc (NYSE: SLDE), executed a planned sale of company stock on April 6 and April 7, 2026, disposing of a total of 56,424 shares for aggregate proceeds in excess of $1 million. The sales were carried out under a pre-established 10b5-1 trading arrangement and posted prices that ranged narrowly between $17.82 and $18.19.
The first tranche, on April 6, comprised 28,212 shares sold at a weighted average price of $18.06. Individual trades that day recorded prices from $17.82 up to $18.19, producing total proceeds of $509,408. On April 7, Gries sold a second block of 28,212 shares at a weighted average of $18.02, with individual trade prices between $17.95 and $18.13, totaling $508,480.
Those holdings were indirectly owned by GRM Family Limited Partnership, an entity controlled by Gries. After these transactions, Gries retains indirect ownership of 1,918,417 shares and holds 843,804 shares directly in Slide Insurance.
Valuation and recent company performance
An InvestingPro analysis referenced alongside the transactions places Slide Insurance at a Fair Value of $20.54, compared with a market price near $18. The stock has declined roughly 11% over the last 12 months, though InvestingPro’s metrics describe Slide Insurance as having a "GREAT" financial health score of 3.73 and show the company remains profitable with trailing twelve-month earnings per share of $3.36.
Slide Insurance’s fourth-quarter 2025 results were highlighted by a notable earnings beat and revenue growth. The company reported fourth-quarter EPS of $1.23, above the $0.71 consensus estimate, while revenue rose to $347 million from $238.5 million in the same period a year earlier. Following those results, Slide Insurance completed a $120 million stock repurchase program and the board approved a new $125 million buyback initiative.
Analyst responses to the quarter were largely positive. Barclays reiterated an Overweight rating with a $29 price target. Texas Capital Securities initiated coverage with a Buy rating and a $25 target. Keefe, Bruyette & Woods raised its price target to $23 from $22 and maintained an Outperform rating, citing the company’s strong fourth-quarter performance.
Context and constraints
The sales by Gries were executed under a 10b5-1 plan, indicating they were pre-arranged transactions. The reporting discloses the precise share counts, price ranges, weighted averages and proceeds for each day. The article presents the company’s recent operating results, capital return activity and several broker assessments as reported.
No additional motives for the sales or undisclosed strategic intentions were provided in the disclosures. Readers should note the factual record above reflects only the reported transactions and company announcements.